Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) does not reduce the effectiveness of the contraceptive implant. Unlike the oral contraceptive pill, the implant works independently of your digestive system — it releases hormones directly into your bloodstream through the skin, so the slower gastric emptying caused by Mounjaro has no effect on it. That said, there are still a few things worth knowing before you start treatment, and your prescriber is the right person to run through your full contraceptive picture. These are prescription-only medicines assessed individually by a clinician before they are dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people searching this question have already read that Mounjaro can interfere with contraception and assumed it applies to every method. It does not. The concern centres specifically on oral contraceptive pills, not on long-acting reversible methods like the implant, the coil, the patch or the injection.
Here is why the distinction matters. Mounjaro slows gastric emptying, meaning food and oral medicines stay in the stomach longer before passing through to the small intestine where absorption happens. For a pill you swallow, that delay can reduce how reliably it is absorbed. The contraceptive implant (a small flexible rod placed under the skin of the upper arm) has no such vulnerability. It releases a low, steady level of progestogen (etonogestrel) directly into the bloodstream, entirely bypassing the gut. There is no absorption step that Mounjaro can disrupt.
This is confirmed in NHS England's guidance on weight-management injections, which specifically highlights oral contraceptives as the method requiring extra precaution with tirzepatide, and makes no such recommendation for implant users. The implant is, in this respect, one of the most straightforward contraceptive choices for people starting Mounjaro.
Even if the implant's hormonal effectiveness is unaffected, significant weight loss can sometimes prompt people to revisit their contraceptive choices for other reasons. Some people find that body-composition changes affect how they feel on hormonal methods generally, though this is not a pharmacological interaction with Mounjaro itself.
There is also the question of fertility. Mounjaro is not recommended during pregnancy, while breastfeeding, or when trying to conceive. For people who previously relied on excess weight as an informal barrier to conception (and there is good evidence that obesity can reduce fertility) effective contraception becomes more important, not less, once treatment begins. A prescriber reviewing your case through Mounjaro treatment will factor this into their assessment.
The MHRA has also noted, separately, that anyone using GLP-1 medicines who wishes to stop contraception and try for a pregnancy should discuss the appropriate wash-out period with their clinician before doing so. That conversation belongs with a prescriber or your GP, not a checklist online.
If you use the contraceptive pill alongside your implant (some people do, for cycle regulation) the pill portion of that arrangement does carry the same precaution as for any oral contraceptive user. NHS guidance advises adding a non-oral barrier method (condoms are the practical example) for the first four weeks of Mounjaro and for four weeks after every dose increase, until absorption of the pill stabilises.
Beyond that combination scenario, implant-only users can generally proceed without additional contraceptive precautions on account of Mounjaro. That does not mean skipping the clinical conversation (a prescriber needs to know all the medicines and devices you use) but it does mean one common source of anxiety about starting treatment simply does not apply here.
There is a fuller breakdown of how Mounjaro interacts with the implant if you want to go deeper, and a separate page covering Mounjaro and the coil for anyone using an IUD or IUS. Questions about Mounjaro's effects beyond contraception (such as whether it affects the eyes) are answered on dedicated pages too.
When you complete a consultation for Mounjaro, list every contraceptive method you use, including the implant. Not because the implant itself creates a problem, but because a complete medicines and devices history lets the prescriber make the right call on everything, dose titration, timing, any other medicines that do interact with slower gastric emptying.
At nume, a GPhC-registered Independent Prescriber reads your answers the same day, not software. Once approved, your treatment is dispatched and arrives via DPD the next working day in plain, unbranded packaging, nothing on the outside to indicate what is inside. For context on what that treatment costs and what is included in the price, the Mounjaro cost page runs through the full picture honestly. If you are ready to get started, you can speak to our prescribers through a free consultation today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.